Shareholders' Equity (Details)							1 Months Ended					6 Months Ended	9 Months Ended	12 Months Ended
	Aug. 03, 2017 USD ($) $ / shares	Jan. 09, 2017 shares	Sep. 29, 2016 USD ($) Investor Affiliateinvestors $ / shares shares	Feb. 04, 2016 USD ($)	Sep. 04, 2015 USD ($) Employees Director shares	Jun. 01, 2015 shares	Apr. 24, 2017 shares	Sep. 30, 2016 USD ($) shares	May 31, 2016	Feb. 04, 2016 shares	Nov. 30, 2015 shares	Jun. 30, 2017 USD ($)	Sep. 30, 2017 USD ($)	Dec. 31, 2017 USD ($) shares	Dec. 31, 2016 USD ($) shares	Dec. 31, 2015 $ / shares
Shareholders' Equity (Textual)
Stock based compensation | $													$ 1,488,596	$ 6,602,806	$ 5,553,026
Gross proceeds from equity | $	$ 7,000,000
Common stock, shares issued														9,182,470	8,682,220
Gain on settlement of make whole provision | $														$ (681,988)
Unamortized stock compensation for non-employees | $														$ 77,500
Private Placement [Member]
Shareholders' Equity (Textual)
Common stock issued, shares			496,667								406,666
Securities sold to investors price per share | $ / shares			$ 5.00
Common stock conversion price | $ / shares			$ 3.00
Issuance of deemed dividend | $			$ 1,641,484
Number of investors | Investor			12
Number of affiliate investors | Affiliateinvestors			4
Stock award agreements [Member]
Shareholders' Equity (Textual)
Shares of restricted common stock issued					450,000
Stock based compensation | $				$ 604,440											$ 508,940
Number of management employees | Employees					4
Number of director | Director					1
Adaptive Flight, Inc. [Member]
Shareholders' Equity (Textual)
Common stock, shares issued															50,000
Escrow share value | $															$ 1,400,000
Gain on settlement of make whole provision | $															11,000
Fair value of assets | $															150,500
Securities sold to investors price per share | $ / shares																$ 3.23
Chairman of the Board [Member]
Shareholders' Equity (Textual)
Shares of restricted common stock issued						50,000
Common stock issued, shares														150,000
Recognized total expense | $														$ 112,500	270,000
Vesting period term						24 months
Dr. Philip Frost and Steven Rubin [Member]
Shareholders' Equity (Textual)
Common stock issued, shares														150,000
Recognized total expense | $														$ 29,500	284,000
Vesting period term									12 months
Fair value of assets | $														$ 82,722
Lt. Gen. Michael T. Flynn [Member]
Shareholders' Equity (Textual)
Stock based compensation | $															$ 97,000
Aggregate shares of restricted common stock															33,333
Common stock, shares issued															100,000
Forfeited unvested shares															66,667
Four management employees and one director [Member]
Shareholders' Equity (Textual)
Common stock issued, shares					450,000					604,440
Payments of financing costs | $					$ 4,000,000
Common Stock [Member]
Shareholders' Equity (Textual)
Shares of restricted common stock issued		50,000
Common stock, shares issued														500,250	3,556,635
2015 Equity Plan [Member]
Shareholders' Equity (Textual)
Shares of restricted common stock issued														5,210,000
Shares vest upon consummation of equity and/or debt financing | $								$ 5,000,000						$ 3,725,000
Stock based compensation | $												$ 970,067	$ 1,488,596
Common stock issued, shares								1,339,000						1,150,000
2015 Equity Plan [Member] | Stock award agreements [Member]
Shareholders' Equity (Textual)
Stock based compensation | $															$ 3,346,615
2015 Equity Plan [Member] | Lt. Gen. Michael T. Flynn [Member]
Shareholders' Equity (Textual)
Aggregate shares of restricted common stock															25,000
Cancelled shares															25,000
2015 Equity Plan [Member] | Reginald Brown, Jr. [Member]
Shareholders' Equity (Textual)
Shares vest upon consummation of equity and/or debt financing | $															$ 11,065
Common stock issued, shares								35,000
SAB Amendments [Member]
Shareholders' Equity (Textual)
Restricted common stock, description	The SAB Amendments extend the term of the agreements from May 1, 2017 until April 30, 2018 and provide for the following equity based compensation: (a) for Dr. Frost, a warrant to purchase 2,000,000 shares of the Company's Common Stock (the "Frost Warrant") and an award of 150,000 shares of the Company's unregistered restricted Common Stock and (b) for Mr. Rubin, an award of 100,000 shares of the Company's unregistered restricted Common Stock. The restricted stock vests upon the occurrence of a change of control (as defined in the SAB Amendments).
Warrant Term	5 years
Warrant exercise price | $ / shares	$ 1.00
Series A Preferred Stock [Member]
Shareholders' Equity (Textual)
Preferred stock converted shares							100,100
Aggregate shares of restricted common stock							250,250
Common stock issued for conversion															2,500
Series A Preferred Stock [Member] | Investors [Member]
Shareholders' Equity (Textual)
Common stock issued for conversion															1,000
Series C Preferred Stock [Member]
Shareholders' Equity (Textual)
Common stock issued for conversion															183,468
Series C Preferred Stock [Member] | Investors [Member]
Shareholders' Equity (Textual)
Common stock issued for conversion															73,387
Series D Preferred Stock [Member]
Shareholders' Equity (Textual)
Common stock issued for conversion															50,000
Series D Preferred Stock [Member] | Investors [Member]
Shareholders' Equity (Textual)
Common stock issued for conversion															2,000,000
Series F Preferred Stock [Member]
Shareholders' Equity (Textual)
Common stock issued for conversion															50,000
Series F Preferred Stock [Member] | Investors [Member]
Shareholders' Equity (Textual)
Common stock issued for conversion															1,999,998
Series G Preferred Stock [Member]
Shareholders' Equity (Textual)
Common stock issued for conversion															50,000
Series G Preferred Stock [Member] | Investors [Member]
Shareholders' Equity (Textual)
Common stock issued for conversion															2,000,000